Answers are grounded in this paper and cite their sources.
Positive-sense RNA viruses are commonly classified by genome organization, entry route, tissue tropism, and clinical syndrome, but these categories do not explain how viruses construct protected replication niches or route infectious material between cells. The endoplasmic reticulum (ER) provides a shared platform for viral translation, replication-organelle formation, membrane curvature, lipid remodeling, innate immune regulation, and vesicular trafficking. Within this framework, reticulon-3 (RTN3) has emerged as a candidate regulator linking ER-based RNA-virus replication to the generation of infectious extracellular-vesicle cargo. Hepatitis C virus (HCV) and dengue virus (DENV) provide complementary experimental settings for evaluating this model despite their distinct transmission routes, tissue tropisms, disease courses, and immune pathophysiology. HCV most clearly demonstrates that exosome-enriched fractions can transfer replication-competent viral RNA with defined host cofactors, whereas DENV provides an acute infection model for examining related transfer phenotypes. Both viruses nevertheless replicate within remodeled ER membranes and can transfer infection-competent material in a vesicle-associated form. Functional perturbation studies implicate RTN3 in the output of infection-associated vesicle preparations, but do not yet establish direct recognition of viral RNA or its incorporation into endosomal intraluminal vesicles. RTN3 can also restrict HCV replication through NS4B interactions, suggesting that its effects vary by endpoint and may reflect distinct functions at different stages of infection. Related membrane-remodeling and vesicle-associated processes in Zika virus, West Nile virus, enteroviruses, SARS-CoV-2, and hepatitis A virus illustrate broader exploitation of host membrane organization, but replication-membrane phenotypes and vesicle-associated dissemination in these systems do not establish an RTN3-dependent infectious EV pathway. In selected models, EV-enriched preparations contain protected viral cargo and transfer biological activity to recipient cells; neither particle enrichment nor infectivity alone resolves the carrier’s identity. Advances in isolation and characterization, including density-gradient or size-exclusion separation, immunoaffinity selection, particle and marker profiling, membrane-protection assays, and recipient-cell infectivity testing, now permit more rigorous identification of defined vesicle populations, protected cargo, and biological activity. Nevertheless, RTN3 should not be considered a universal RNA-virus dependency, nor should extracellular-vesicle release be assumed to generate uniformly infectious populations. Instead, HCV and DENV support functional involvement of RTN3 in vesicle-associated output, while the molecular connection between ER organization and selective cargo enclosure remains unresolved. Defining these shared and virus-specific dependencies may reveal host–virus interfaces suitable for broad-spectrum or resistance-resilient intervention, provided that infection-selective reliance, a measurable therapeutic window, and preservation of essential host-cell functions can be demonstrated.
No takes yet. Share an insight, caveat, or question.
Noumi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: